Category: clinical study retractions

Failure to cite leads to ignoble end for xenon paper, and a correction

anaesthesiaXenon may be an inert gas, but that doesn’t mean papers about the molecule aren’t subject to change.

Indeed, the journal Anaesthesia has retracted a 2010 article about xenon-based anesthesia, and corrected a 2005 article by some of the same researchers, for what appears to be a case of wurst slicing.

The 2005 paper, “Comparison of xenon-based anaesthesia compared with total intravenous anaesthesia in high risk surgical patients,” came from a group at the Department of Anaesthesiology and Intensive Care Medicine at University Hospital Schleswig-Holstein, in Kiel, Germany. It has been cited 10 times, according to Thomson Scientific’s Web of Knowledge.

According to the abstract: Continue reading Failure to cite leads to ignoble end for xenon paper, and a correction

Diabetes researcher who says he will no longer publish now up to five retractions

toth
Cory Toth, via U Calgary

Cory Toth, the University of Calgary diabetes researcher who told us last month he would stop publishing in science following a string of inappropriate manipulations, has retracted another paper.

Here’s the notice in Brain for “Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy:” Continue reading Diabetes researcher who says he will no longer publish now up to five retractions

Oncology researcher Getzenberg notches seventh retraction

GetzenbergRobert Getzenberg, a former Hopkins and Pitt cancer researcher, has retracted another paper, his seventh.

Here’s the notice for “Highly specific urine-based marker of bladder cancer,” a paper first published in Urology in 2005: Continue reading Oncology researcher Getzenberg notches seventh retraction

Forged authorship sinks melanoma paper

ijbcbThe International Journal of Biochemistry & Cell Biology has retracted a 2013 paper by a group from China after learning that only the first author knew about the article.

The paper was titled “Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells,” and it was led by Yuchen Liu. Liu’s affiliations include the Institute of Dermatology and Department of Dermatology at No. 1 Hospital, part of Anhui Medical University, and the State Key Laboratory Incubation Base of Dermatology for the Ministry of National Science and Technology.

Here’s the retraction notice:
Continue reading Forged authorship sinks melanoma paper

Ninth retraction appears for cardiology researcher Matsubara

matsubaraHiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher who resigned last year following an investigation, has had another paper retracted, his ninth.

Here’s the notice from Arteriosclerosis, Thrombosis, and Vascular Biology: Continue reading Ninth retraction appears for cardiology researcher Matsubara

“Blameworthy inaccuracies:” Dirk Smeesters up to six retractions

smeestersDirk Smeesters, the former Erasmus University psychology researcher found to have committed misconduct, is up to half a dozen retractions.

Both notices, in the Journal of Consumer Research, where Smeesters has already had one retraction, are paywalled. Here’s one, for a paper cited seven times, according to Thomson Scientific’s Web of Knowledge: Continue reading “Blameworthy inaccuracies:” Dirk Smeesters up to six retractions

Nothing to see here: Unreplicable eye paper ends in retraction

jneuroimmunoThe authors of a 2012 paper in the Journal of Neuroimmunology have retracted the paper after some of the researchers were unable to verify the findings in follow-up work.

The article, “Association of transforming growth factor beta-1 (TGFB1) regulatory region polymorphisms with myasthenia gravis-related ophthalmoparesis,” came from a lab at Groote Schuur Hospital and the University of Cape Town, in South Africa.

According to the abstract: Continue reading Nothing to see here: Unreplicable eye paper ends in retraction

Lactobacillus intolerance: Bacterium mixup forces retraction

bjncoverThe British Journal of Nutrition has retracted a 2013 paper by a group of researchers from Taiwan after learning that the authors had studied the wrong strain of microbe.

The article was titled “Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus.”

According to the abstract: Continue reading Lactobacillus intolerance: Bacterium mixup forces retraction

Stunner: Researchers retract paper because company complains it’s hurting profits

ajfsIt’s not unusual for us to hear allegations that journals have caved to corporate demands that they retract papers. And companies have certainly objected to the publication of results that painted their products in an unflattering light.

Continue reading Stunner: Researchers retract paper because company complains it’s hurting profits

BMJ authors take back inaccurate statin safety statements

bmjcover514Last October, the BMJ published a paper by a group of researchers from the United States and Canada questioning the use of statins in patients considered at low risk of cardiovascular disease.

The article has been cited eight times since then, according to Thomson Scientific’s Web of Knowledge. It mentioned data from another study that reported a high rate of side effects in patients who used the drugs, between 18% and 20% — suggesting that those who received little or no benefit from the therapy could be more more likely to suffer harm than good.

But that citation turns out to have been flawed — prompting the journal to take the unusual step of removing those “statements” from the article and another it published about the issue that has been cited six times. And in an editorial, BMJ editor Fiona Godlee said she has asked a panel of experts to review the original paper to determine if it ought to be retracted completely: Continue reading BMJ authors take back inaccurate statin safety statements